Elubrixin 是一种有效和特异性的 CXCR2 和 IL-8 受体拮抗剂。 Elubrixin 可用于炎症性疾病的研究，例如炎症性肠病和气道炎症。

Elubrixin inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin can be used for inflammatory diseases such as inflammatory bowel disease and airway inflammation. Elubrixin is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist.

Elubrixin inhibits neutrophil CD11b upregulation with an IC50 of 260.7 nM and shapes change with an IC50 of 310.5 nM. Elubrixin has an inhibitory effect on neutrophils in a dose-dependent manner[3].

688763-64-6

C17H17Cl2FN4O4S

463.31

SB-656933

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years